Overview

Acetyl Salicylic Elimination Trial: The ASET Pilot Study

Status:
Unknown status
Trial end date:
2019-08-15
Target enrollment:
Participant gender:
Summary
A multicenter, single arm, open-label trial of prasugrel monotherapy after PCI with the new-generation thin-strut biodegradable polymer everolimus-eluting SYNERGY® stent in patients with chronic stable angina
Phase:
N/A
Details
Lead Sponsor:
Pedro A. Lemos
Collaborators:
Cardialysis B.V.
Imperial College London
Treatments:
Prasugrel Hydrochloride
Salicylic Acid